Abstract:Copy number variants (CNVs) represent the genetic cause of about 15–20% of neurodevelopmental disorders (NDDs). We identified a ~67 kb de novo intragenic deletion on chromosome 2q22.3 in a female individual showing a developmental encephalopathy characterised by epilepsy, severe intellectual disability, speech delay, microcephaly, and thin corpus callosum with facial dysmorphisms. The microdeletion involved exons 5-6 of GTDC1 , encoding a putative glycosyltransferase, whose expression is particularly enriched in the nervous system. In a previous study, a balanced de novo translocation encompassing GTDC1 was reported in a male child with global developmental delay and delayed speech and language development. Based on these premises, we explored the transcriptomic profile of our proband to evaluate the functional consequences of the novel GTDC1 de novo intragenic deletion in relation to the observed neurodevelopmental phenotype. RNA-seq on the proband's lymphoblastoid cell line (LCL) showed expression changes of glycine/serine and cytokine/chemokine signalling pathways, which are related to neurodevelopment and epileptogenesis. Subsequent analysis by ELISA (enzyme-linked immunosorbent assay) and HPLC (high-performance liquid chromatography) revealed increased levels of glycine in the proband's LCL and serum compared to matched controls. Given that an increased level of glycine has been observed in the plasma samples of individuals with Rett syndrome, a condition sharing epilepsy, microcephaly, and intellectual disability with our proband, we proposed that the GTDC1 downregulation is implicated in neurodevelopmental impairment by altering glycine metabolism. Furthermore, our findings expanded the phenotypic spectrum of the novel GTDC1 -related condition, including microcephaly and epilepsy among relevant clinical features.

Tissue-specific DNase I footprint analysis confirms the association of GATAD2B Q470* variant with intellectual disability

Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases

A novel mutation in the GATAD2B gene associated with severe intellectual disability

GATAD2B Gene Microdeletion Causing Intellectual Disability Autosomal Dominant Type 18: Case Report and Review of the Literature

Intellectual disability due to monoallelic variant in GATAD2B and mosaicism in unaffected parent

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

Gatad2b , associated with the neurodevelopmental syndrome GAND, plays a critical role in neurodevelopment and cortical patterning

A novel heterozygous ZBTB18 missense mutation in a family with non-syndromic intellectual disability and structural brain abnormalities

GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila

A Novel Missense ZBTB18 Mutation Identified in an Intellectual Disability Family by Whole Genome Sequencing

1q21.3 deletion involving GATAD2B: An emerging recurrent microdeletion syndrome

Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND)

Biallelic missense variants in ZBTB11 can cause intellectual disability in humans

Biallelic HMGXB4 loss-of-function variant causes intellectual disability, developmental delay, and dysmorphic features

Regulatory De Novo Mutations Underlying Intellectual Disability

A novel genomic mutation in ADNP leading to intellectual disability

The first case of intellectual disability caused by novel compound heterozygosity for NUDT2 variants

The diagnostic yield, candidate genes, and pitfalls for a genetic study of intellectual disability in 118 middle eastern families

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability

Further evidence supporting the role of GTDC1 in glycine metabolism and neurodevelopmental disorders

Whole exome sequencing coupled with in silico functional analysis identified NID1 as a novel candidate gene causing neuro-psychiatric disorder in a Pakistani family